114 related articles for article (PubMed ID: 16698096)
1. REMOVED: Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase 2 study evaluating a prolonged high dose of boronophenylalanine (BPA).
Henriksson R; Capala J; H-Stenstam B; Michanek A; Lindahl SK; Salford L; Franzén L; Blomquist E; Westlin JE; Bergenheim AT
Radiother Oncol; 2006 May; ():150-157. PubMed ID: 16698096
[TBL] [Abstract][Full Text] [Related]
2. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT;
Radiother Oncol; 2008 Aug; 88(2):183-91. PubMed ID: 18336940
[TBL] [Abstract][Full Text] [Related]
3. REMOVED: Boron neutron capture therapy in the treatment of glioblastoma: As effective, more effective or less effective than photon irradiation?
Barth RF; Joensuu H
Radiother Oncol; 2006 May; ():142-144. PubMed ID: 16684574
[TBL] [Abstract][Full Text] [Related]
4. Comments to article: Henriksson R et al., Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA) Radiother Oncol (2008).
H-Stenstam B
Radiother Oncol; 2008 Aug; 88(2):287-8; author reply 288. PubMed ID: 18617284
[No Abstract] [Full Text] [Related]
5. Quantitative subcellular imaging of boron compounds in individual mitotic and interphase human glioblastoma cells with imaging secondary ion mass spectrometry (SIMS).
Chandra S; Tjarks W; Lorey DR; Barth RF
J Microsc; 2008 Jan; 229(Pt 1):92-103. PubMed ID: 18173648
[TBL] [Abstract][Full Text] [Related]
6. REMOVED: Ion changes and signalling in perisynaptic glia.
Deitmer JW; Rose CR
Brain Res; 2009 Oct; ():. PubMed ID: 19835850
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic success of boron neutron capture therapy (BNCT) mediated by a chemically non-selective boron agent in an experimental model of oral cancer: a new paradigm in BNCT radiobiology.
Trivillin VA; Heber EM; Nigg DW; Itoiz ME; Calzetta O; Blaumann H; Longhino J; Schwint AE
Radiat Res; 2006 Aug; 166(2):387-96. PubMed ID: 16881740
[TBL] [Abstract][Full Text] [Related]
8. REMOVED: Association between the BDNF C270T polymorphism and negative symptoms of schizophrenia.
Tan YL; Zhou DF; Cao LY; Zou YZ; Wu GY; Yang Zhang X
Schizophr Res; 2006 Jul; ():. PubMed ID: 16846718
[TBL] [Abstract][Full Text] [Related]
9. REMOVED: Comparing the reproducibility of intima-media thickness measurements using spectral analysis.
Sandrock M; Hansel J; Schmitz D; Schulz J; Burkhardt H; Schmidt-Trucksass A; Niess AM
Atherosclerosis; 2008 Jun; ():. PubMed ID: 18621372
[TBL] [Abstract][Full Text] [Related]
10. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
[TBL] [Abstract][Full Text] [Related]
11. Removed: Integrative differential gene expression analysis for cross-platform microarray datasets.
Pan F; Ma X; Zhou XJ
J Biomed Inform; 2006 Aug; ():. PubMed ID: 17027342
[TBL] [Abstract][Full Text] [Related]
12. REMOVED: Statin prevents plaque disruption in apoE-knockout mouse model through pleiotropic effect on acute inflammation.
Nakamura K; Sasaki T; Cheng X; Iguchi A; Sato K; Kuzuya M
Atherosclerosis; 2008 Jul; ():. PubMed ID: 18707687
[TBL] [Abstract][Full Text] [Related]
13. REMOVED: Allyl isothiocyanate influences in vitro invasion, adhesion and gene expression in SK-Hep1 cells.
Hwang ES; Kim GH
J Nutr Biochem; 2006 Dec; ():. PubMed ID: 17142031
[TBL] [Abstract][Full Text] [Related]
14. REMOVED: Novel aminoquinonoid analogues of diospyrin: Synthesis, antitumour activity and preliminary QSAR studies.
Sarma MD; Ghosh R; Patra A; Sharma P; Ghoshal N; Hazra B
Bioorg Med Chem; 2006 Aug; ():. PubMed ID: 16904899
[TBL] [Abstract][Full Text] [Related]
15. Boron neutron capture therapy for glioblastoma.
Yamamoto T; Nakai K; Matsumura A
Cancer Lett; 2008 Apr; 262(2):143-52. PubMed ID: 18313207
[TBL] [Abstract][Full Text] [Related]
16. Boron neutron capture therapy (BNCT) inhibits tumor development from precancerous tissue: an experimental study that supports a potential new application of BNCT.
Monti Hughes A; Heber EM; Pozzi E; Nigg DW; Calzetta O; Blaumann H; Longhino J; Nievas SI; Aromando RF; Itoiz ME; Trivillin VA; Schwint AE
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S313-7. PubMed ID: 19376711
[TBL] [Abstract][Full Text] [Related]
17. Effect of Boron Neutron Capture Therapy (BNCT) on normal liver regeneration: towards a novel therapy for liver metastases.
Cardoso JE; Trivillin VA; Heber EM; Nigg DW; Calzetta O; Blaumann H; Longhino J; Itoiz ME; Bumaschny E; Pozzi E; Schwint AE
Int J Radiat Biol; 2007 Oct; 83(10):699-706. PubMed ID: 17729164
[TBL] [Abstract][Full Text] [Related]
18. Survival benefit from boron neutron capture therapy for the newly diagnosed glioblastoma patients.
Kawabata S; Miyatake S; Nonoguchi N; Hiramatsu R; Iida K; Miyata S; Yokoyama K; Doi A; Kuroda Y; Kuroiwa T; Michiue H; Kumada H; Kirihata M; Imahori Y; Maruhashi A; Sakurai Y; Suzuki M; Masunaga S; Ono K
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S15-8. PubMed ID: 19398348
[TBL] [Abstract][Full Text] [Related]
19. Insight into the mechanisms underlying tumor response to boron neutron capture therapy in the hamster cheek pouch oral cancer model.
Aromando RF; Heber EM; Trivillin VA; Nigg DW; Schwint AE; Itoiz ME
J Oral Pathol Med; 2009 May; 38(5):448-54. PubMed ID: 19141057
[TBL] [Abstract][Full Text] [Related]
20. T2 corrected quantification method of L-p-boronophenylalanine using proton magnetic resonance spectroscopy for boron neutron capture therapy.
Yamamoto Y; Isobe T; Yamamoto T; Shibata Y; Anno I; Nakai K; Shirakawa M; Matsushita A; Sato E; Matsumura A
Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S345-7. PubMed ID: 19406648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
